Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis,
Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers
Categories
Health Care
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net income attributable
UnitedHealth Group Incorporated (UNH) Q2 2022 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q2 2022 earnings call dated Jul. 15, 2022 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President &
Organigram Holdings Inc. (OGI) Q3 2022 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q3 2022 earnings call dated Jul. 14, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff
Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have brought both
Despite generic threat, AbbVie (ABBV) remains a good long-term bet
Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from generic competitors
Angiodynamics Inc (ANGO) Q4 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment
Walgreens Boots Alliance (WBA) Q3 profit drops on lower revenues; results beat
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday said its third-quarter revenues decreased. As a result, the healthcare service company's adjusted profit
Walgreens Boots Alliance Inc (WBA) Q3 2022 Earnings Call Transcript
Walgreens Boots Alliance Inc (NASDAQ: WBA) Q3 2022 earnings call dated Jun. 30, 2022 Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor Relations
ANGO Stock: Is it the right time to invest in AngioDynamics now?
The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But
Patterson Companies Inc (PDCO) Q4 2022 Earnings Call Transcript
Patterson Companies Inc (NASDAQ: PDCO) Q4 2022 earnings call dated Jun. 29, 2022 Corporate Participants: John M. Wright -- Vice President, Investor Relations Mark
Avid Bioservices Inc (CDMO) Q4 2022 Earnings Call Transcript
Avid Bioservices Inc (NASDAQ: CDMO) Q4 2022 earnings call dated Jun. 29, 2022 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President and Chief
Rite Aid Corporation (RAD) Q1 2023 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q1 2023 earnings call dated Jun. 23, 2022 Corporate Participants: Byron Purcell -- Investor Relations Heyward Donigan -- President & CEO
Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for
OptMed all set for $24 million IPO. Here’s what you need to know
As IPO activity picks up momentum after a lull, technology and healthcare companies are dominating the scene as usual. The upcoming initial
Stock Watch: Key factors to consider before investing in Medtronic (MDT)
More than two years into the pandemic, the healthcare sector remains under stress due to continuing COVID care activities and hospitalizations. However,
HealthEquity Inc. (HQY) Q1 2023 Earnings Call Transcript
HealthEquity Inc. (NASDAQ: HQY) Q1 2023 earnings call dated Jun. 06, 2022 Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President and Chief Executive
MDT Earnings: Highlights of Medtronic’s Q4 2022 results
Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite a modest
Canopy Growth Corporation (WEED) Q4 2022 Earnings Call Transcript
Canopy Growth Corporation (TSE: WEED) Q4 2022 earnings call dated May. 27, 2022 Corporate Participants: Tyler Burns -- Director, Investor Relations David Klein -- Chief Executive